Namodenoson Inhibits the Growth of Pancreatic Carcinoma via Deregulation of the Wnt/β-catenin, NF-κB, and RAS Signaling Pathways

Inbal Itzhak, Avital Bareket-Samish, Pnina Fishman

Open source

DOI
10.3390/biom13111584
Published
2023-10-27
Container
Biomolecules
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biom13111584,
  title = {Namodenoson Inhibits the Growth of Pancreatic Carcinoma via Deregulation of the Wnt/β-catenin, NF-κB, and RAS Signaling Pathways},
  author = {Inbal Itzhak and Avital Bareket-Samish and Pnina Fishman},
  year = {2023},
  journal = {Biomolecules},
  doi = {10.3390/biom13111584},
  url = {https://doi.org/10.3390/biom13111584}
}

RIS

TY  - JOUR
TI  - Namodenoson Inhibits the Growth of Pancreatic Carcinoma via Deregulation of the Wnt/β-catenin, NF-κB, and RAS Signaling Pathways
AU  - Inbal Itzhak
AU  - Avital Bareket-Samish
AU  - Pnina Fishman
PY  - 2023
JO  - Biomolecules
DO  - 10.3390/biom13111584
UR  - https://doi.org/10.3390/biom13111584
ER  - 

APA

Itzhak, I., Bareket-Samish, A., & Fishman, P. (2023). Namodenoson Inhibits the Growth of Pancreatic Carcinoma via Deregulation of the Wnt/β-catenin, NF-κB, and RAS Signaling Pathways. Biomolecules. https://doi.org/10.3390/biom13111584

Source records